Trials / Completed
CompletedNCT01318837
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
Reproducibility Study of OABSS and Its Response to Solifenacin Treatment (RESORT) and Validity in Korean Populations; Part 2: Responsiveness and Validity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate change of over active bladder symptom scores (OABSS) between, before and after solifenacin treatment to OAB subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | solifenacin | oral |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-03-21
- Last updated
- 2014-07-10
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01318837. Inclusion in this directory is not an endorsement.